NCT01528059

Brief Summary

Gastric bypass improves glycemic levels in type 2 diabetes. However, the efficacy may be varied by different gastric-small intestine reconstruction used in the procedure. There are reports that Roux en Y reconstruction may give a better result. The purpose of this study is to compare Roux en Y and Billroth II reconstruction in patients with gastric cancer comorbid with type 2 diabetes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
110

participants targeted

Target at P75+ for phase_2 gastric-cancer

Timeline
Completed

Started Feb 2012

Shorter than P25 for phase_2 gastric-cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2012

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

February 2, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 7, 2012

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2013

Completed
Last Updated

February 7, 2012

Status Verified

February 1, 2012

Enrollment Period

Same day

First QC Date

February 2, 2012

Last Update Submit

February 6, 2012

Conditions

Keywords

DiabetesGastric cancerGastric bypass

Outcome Measures

Primary Outcomes (1)

  • Glycemic control

    1. Fasting and postprandial glycemic levels, HbA1C 2. Number of anti-diabetic drugs 3. Dosage of anti-diabetic drugs

    1 year after surgery

Secondary Outcomes (1)

  • Nutritional status assessment

    1 year after surgery

Study Arms (2)

Billroth II

ACTIVE COMPARATOR

After stomach resection, the remnant stomach is connected to the jejunum.

Procedure: Stomach-small intestine reconstruction

Roux en Y

ACTIVE COMPARATOR

After stomach resection, the remnant stomach is connected to the distal jejunum while duodenum and the proximal jejunum is reconnected to jejunum.

Procedure: Stomach-small intestine reconstruction

Interventions

Billroth II or Roux en Y reconstruction will be performed after gastric resection in stomach patients co-morbid with type 2 diabetes

Billroth IIRoux en Y

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with Type 2 diabetes
  • Diagnosed with gastric cancer

You may not qualify if:

  • Type 1 diabetes
  • Unresectable cancers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

DongFang Hospital

Fuzhou, Fujian, 350025, China

RECRUITING

MeSH Terms

Conditions

Stomach NeoplasmsDiabetes Mellitus, Type 2Diabetes Mellitus

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Yu Wang, M.D

    Dongfang Hospital, Xiamen University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Zhongdong Zhou, M.D

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

February 2, 2012

First Posted

February 7, 2012

Study Start

February 1, 2012

Primary Completion

February 1, 2012

Study Completion

March 1, 2013

Last Updated

February 7, 2012

Record last verified: 2012-02

Locations